Vestal Point Capital »

Achilles Therapeutics shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Achilles Therapeutics (ACHL) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Achilles Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Achilles Therapeutics held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Achilles Therapeutics by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.7M 1.5M 1.14
2024-09-30 $1.5M 1.5M 1.02
2024-06-30 $1.2M 1.5M 0.82

More positions owned by Vestal Point Capital

Ascendis Pharma A/S Sponsored Adr (ASND)
Arcellx Common Stock (ACLX)
Nuvalent Inc-a (NUVL)
Abivax SA Sponsored Ads (ABVX)
Alcon Ord Shs (ALC)
Bicara Therapeutics (BCAX)
Amicus Therapeutics (FOLD)
Globus Medical Cl A (GMED)
Ionis Pharmaceuticals (IONS)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Becton, Dickinson and (BDX)
Scholar Rock Hldg Corp (SRRK)
Immatics NV SHS (IMTX)
Repligen Corporation (RGEN)
Dianthus Therapeutics (DNTH)

View all positions for Vestal Point Capital

Top funds holding Achilles Therapeutics

Rhumbline Advisers
GAMMA Investing

View all funds holding Achilles Therapeutics